Mirapexin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Mirapexin, covering 2010-09-20 to 2024-05-02. Get the full timeline:
Most recent: EMA Authorised: Mirapexin (pramipexole dihydrochloride monohydrate) — Boehringer Ingelheim International GmbH